Press Release
Consult the important information that Servier Canada wishes to share with the press in the form of press releases.
2024, October 22
Health Canada Approves First and Only Oral Targeted Treatment for Brain Cancer
2023, June 5
Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma
2024, February 20